Workflow
Prnewswire
icon
Search documents
Telix Pharmaceuticals Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - TLX
Prnewswire· 2025-11-18 20:03
Accessibility StatementSkip Navigation WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and ...
Synopsys Demonstrates Framework for Optimizing Manufacturing Processes with Digital Twins at Microsoft Ignite
Prnewswire· 2025-11-18 20:00
Accessibility StatementSkip Navigation Digital twins and simulation optimize manufacturing processes in near real-time "For manufacturers, the ability to optimize dynamic processes in real-time has been a massive challenge, as traditional, high-fidelity simulation is often too slow to be practical for immediate factory-floor decisions," said Rev Lebaredian, Vice President of Omniverse and Simulation Technology at NVIDIA. "By integrating Synopsys' accelerated physics solvers and NVIDIA Omniverse libraries on ...
CROWN ANNOUNCES PRICING TERMS OF CASH TENDER OFFER FOR DEBT SECURITIES
Prnewswire· 2025-11-18 19:51
TAMPA, Fla. , Nov. 18, 2025 /PRNewswire/ -- Crown Holdings, Inc. (NYSE: CCK) ("Crown") today announced the pricing terms for the previously announced cash tender offer (the "Tender Offer") by its wholly-owned subsidiary Crown Cork & Seal Company, Inc. (the "Company") to purchase any and all of the Company's 7 3/8% Debentures due 2026 (the "Debentures"). ...
ATYR INVESTOR NOTICE: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman
Prnewswire· 2025-11-18 19:03
Accessibility StatementSkip Navigation SAN FRANCISCO, Nov. 18, 2025 /PRNewswire/ -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. The suits allege that aTyr and its top executives made false and misleading statements about the efficacy of its drug, Efzofitimod, leading investors to purchase stock at artificially inflated prices. At the heart ...
CEPTON, INC. (NASDAQ: CPTN) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by December 8, 2025
Prnewswire· 2025-11-18 18:21
Caitlin AdorniDirector of Portfolio & Institutional Client Monitoring ServicesBerger Montague(267) 764- 4865[email protected] Accessibility StatementSkip Navigation PHILADELPHIA, Nov. 18, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Cepton, Inc. (NASDAQ: CPTN) ("Cepton" or the "Company") on behalf of investors who purchased or sold Cepton shares during the period of July 29, 2024 through January 6, 2025 (the "Class Period"). Investor Deadl ...
ATTENTION NYSE: JHX INVESTORS: Contact Berger Montague About a James Hardie Industries PLC Class Action Lawsuit
Prnewswire· 2025-11-18 18:06
Accessibility StatementSkip Navigation 21% The Complaint alleges that during the Class Period, James Hardie misled investors about the strength of its core North America Fiber Cement segment. The Company is alleged to have represented that demand remained strong and inventory levels were normal, despite knowing by April and early May 2025 that distributors were destocking inventory. On August 19, 2025, James Hardie revealed a 12% decline in the segment, attributing it to the "normalization of channel invent ...
SAP joins forces with France's AI ecosystem to power Europe's sovereign digital future
Prnewswire· 2025-11-18 18:00
Core Insights - SAP SE has announced a collaboration with France's AI sector, including partnerships with Bleu, Capgemini, and Mistral AI, to create secure, scalable, AI-driven sovereign cloud solutions aimed at advancing Europe's digital transformation [1][9]. Group 1: Collaboration and Partnerships - The collaboration combines SAP's enterprise application expertise with France's AI ecosystem to enhance data protection and intellectual property while promoting European innovation [1][2]. - Bleu and Delos Cloud have formed a Franco-German alliance to safeguard Europe's digital infrastructure, focusing on crisis response and operational cooperation in extreme scenarios [2][3]. - SAP and Capgemini are deepening their partnership to enhance cybersecurity and accelerate AI-driven enterprise transformation solutions across Europe [5]. Group 2: Sovereign AI and Digital Sovereignty - SAP and Mistral AI are expanding their partnership to provide a full sovereign AI stack for Europe, integrating Mistral's AI capabilities into SAP's cloud infrastructure [6][8]. - The collaboration aims to develop industry-specific AI applications that leverage both companies' strengths to address complex challenges and unlock new business value [7][8]. - SAP is investing over €20 billion in sovereign cloud and AI solutions to create a resilient digital foundation for European governments, public institutions, and enterprises [9].
AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma
Prnewswire· 2025-11-18 17:47
-Â Â EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) Â is now the first and only bispecific antibody combination therapy available for patients with relapsed or refractory follicular lymphoma after at least one line of systemic therapy -Â Â In the Phase 3 EPCORE® FL-1 trial, EPKINLY + R2 demonstrated significantly superior progression-free survival and overall response rates compared to standard of care R2 with approximately 3 out of 4 patients achieving a complete response -Â Â Approval marks third ...
blueharbor bank Announces Cash Dividend
Prnewswire· 2025-11-18 17:42
blueharbor bank (the "Bank") today reported earnings for the third quarter of 2025. Third Quarter 2025 Highlights Return on average assets (ROA) of 2.... blueharbor bank Reports Second Quarter 2025 Net Income MOORESVILLE, N.C., Nov. 18, 2025 /PRNewswire/ -- blueharbor bank (OTCQX-BLHK) announced today that its Board of Directors has declared a special dividend of $0.25 per share payable on December 12, 2025, to holders of record of its common stock on December 2, 2025. Jim Marshall, President and Chief Exec ...
Plug and Play Expands to Washington, D.C. to Accelerate Collaboration between Government Agencies and Startups
Prnewswire· 2025-11-18 17:03
SUNNYVALE, Calif., Nov. 18, 2025 /PRNewswire/ -- Plug and Play, the world's largest innovation platform and early-stage venture capital firm, today announced its official expansion into Washington, D.C. through a new partnership with Consortium Management Group, Inc. (CMG). Together, the organizations will launch CMG-X powered by Plug and Play, an innovation hub designed to accelerate collaboration between government, industry, and world-class startups. The announcement was made during the Plug and Play Sil ...